Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Stephan Stilgenbauer Kari Hemminki Daniel Mertens Peter Lichter Hartmut Döhner Christof M Hofele Rajiv Kumar Gunnar Steineck |
| Publication date | April 1, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |